Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034 · cited 1×
“In the RV144 Thai phase III trial,(9) a reduced risk of infection (31%) in vaccinated individuals did not correlate with serum neutralizing activities but with high concentrations of anti-V1-V2 NoNAbs,(10) providing additional support for a possible contribution of NoNAb functions to protection.(9) Neutralization is t…”
BackgroundImmune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T., Montefiori, D. C., Karnasuta, C., Sutthent, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113425 · Cited by 1,808
Self-citationFc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901 · cited 3×
“Involvement of Fc-mediated inhibition following human mAb transfer has been previously demonstrated by b12mutant LALA.3 Indeed, IgG1 from human or macaque origin showed identical FcgR interaction and ADCC effector function profile in both human and NHP cells.32 We further demonstrated that the Fc-mediated inhibitory a…”
BackgroundParren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Hessell, A. J., Poignard, P., Hunter, M., Hangartner, L., Tehrani, D. M., Bleeker, W. K., Parren, P. W. H. I., Marx, P. A., & Burton, D. R. (2009) · Nature Medicine · doi:10.1038/nm.1974 · Cited by 546 · cited 1×
“Furthermore, subsequent passive infusion studies demonstrated that the protective efficacy of this NAb against vaginal SHIV challenge was significantly reduced by the LALA mutation that impaired its binding to Fcg receptors (FcgRs).(3,12) Mechanisms by which the Fc region of immunoglobulin G (IgG) participates in this…”
BackgroundBUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529 · cited 1×
“Shortly, nAbs 2G12, 2F5, and 4E10were expressed in Chinese hamster ovary cells as human IgG1 (k).(29,44) NoNAbs anti-PID 246-D IgG1 (k) and 4B3 (IgG1 (l) were expressed in hybridoma cells.”
BackgroundHessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000433 · Cited by 497
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Barouch, D. H., Liu, J., Li, H., Maxfield, L. F., Abbink, P., Lynch, D. M., Iampietro, M. J., SanMiguel, A., Seaman, M. S., Ferrari, G., et al. (2012) · Nature · doi:10.1038/nature10766 · Cited by 465 · cited 1×
“Mechanisms by which the Fc region of immunoglobulin G (IgG) participates in this protection are not fully understood.(6,8,13,14) Antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cell-mediated virus replication inhibition require binding to FcgRs expressed by killer cells and lead to the killing o…”
BackgroundMoldt, B., Rakasz, E. G., Schultz, N., Chan-Hui, P.-Y., Swiderek, K., Weisgrau, K. L., Piaskowski, S. M., Bergman, Z., Watkins, D. I., Poignard, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214785109 · Cited by 463 · cited 1×
“The observed protectionwould likely be further improved with combinations of newer generation of very potent, broadly neutralizingAbs, where their increased potency might allow for dose-sparing effects.(36) Interestingly, although not preventing infection, a modest decrease in viral load was observed in several of the…”
Background
Cited by
Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Chen, Y., Zhao, X., Zhou, H., Zhu, H., Jiang, S., & Wang, P. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00784-3 · Cited by 383
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
Excler, J.-L., Ake, J., Robb, M. L., Kim, J. H., & Plotkin, S. A. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00230-14 · Cited by 114
Amadori, C., van der Velden, Y. U., Bonnard, D., Orlov, I., van Bel, N., Le Rouzic, E., Miralles, L., Brias, J., Chevreuil, F., Spehner, D., et al. (2017) · Retrovirology · doi:10.1186/s12977-017-0373-2 · Cited by 22
Self-citation
Metadata
- Authors
- Moog, C., Dereuddre-Bosquet, N., Teillaud, J.-L., Biedma, M. E., Holl, V, Van Ham, G., Heyndrickx, L., Van Dorsselaer, A., Katinger, D., Vcelar, B., Zolla-Pazner, S., Mangeot, I., Kelly, C., Shattock, R. J., & Le Grand, R.
- Venue
- Mucosal Immunology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 7
- Issue
- 1
- Pages
- 46-56
- ISSN
- 1933-0219 (ISSN-L)
- OpenAlex
- W1993675648
- Cited by
- 158
- References
- 35
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.